Taiho Oncology, Inc.
Bob Stewart has a diverse work experience in the pharmaceutical industry. Bob started their career at sanofi aventis in 2002, where they held various roles including Sales Rep, Reimbursement Manager, and District Manager until 2006. Bob then moved on to Encysive Pharmaceuticals, where they worked as a Northeast Regional Business Director in 2006, before transitioning to Abraxis Oncology as a District Manager from 2007 to 2010. In 2011, they joined Archimedes Pharma as the Northeast Regional Sales Manager. Bob later worked at sanofi-aventis as an Access and Reimbursement Manager from 2012 until 2015. Currently, they are serving as the Director of Market Access at Taiho Oncology, Inc. since 2015.
Bob Stewart attended Rider University from 1982 to 1986, where they obtained a Bachelor of Science (BS) degree with a major in Marketing.
This person is not in the org chart
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com